It's often tied to high blood pressure and type 2 diabetes, the FDA explained in a statement. “Previously, patients with NASH who also have notable liver scarring did not have a medication that ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips In the biotech and pharmaceutical world, FDA approval is the ...
Instead, Galiatsatos said, the FDA approved the drug based on other signs of effectiveness, including whether patients were able to walk farther in six minutes than they could before they started ...
The Food and Drug Administration on Monday approved a gene therapy for metachromatic leukodystrophy, a devastating genetic disorder that eats away at affected children’s neurons. The medicine ...
The US Food and Drug Administration has approved a fusion protein made by Merck & Co. for a rare, life-threatening lung disorder. The drug, called sotatercept and set to be marketed under the name ...
The FDA has approved the first gene therapy for children with a rare genetic disease called metachromatic leukodystrophy (MLD), which was made by a Boston-London biotech. The treatment ...
The FDA approved a new treatment for uncontrolled high blood pressure. The once-daily oral medication, called Tryvio (aprocitentan), is expected to be available in the second half of 2024.
HC Wainwright notes the FDA’s worries regarding the potential inability of children, particularly those under the age of 5, to process certain additives in the current medication formulation fully.
Instead, Galiatsatos said, the FDA approved the drug based on other signs of effectiveness, including whether patients were able to walk farther in six minutes than they could before they started ...